Dexamethasone 8 mg injections instructions for use. Dexamethasone injections - instructions for use, for which eye drops and tablets are prescribed, price. What does Dexamethasone help with?

10.07.2020 Glucometers

DEXAMETHASONE instructions for use (injections in ampoules, eye drops, tablets). DEXAMETHASONE is a powerful synthetic glucocorticoid (containing adrenal cortex hormones and their synthetic analogues) drug designed to regulate protein, carbohydrate and mineral metabolism.

Dexamethasone instructions for use, reviews, analogs and forms of release (tablets 0.5 mg, injections in ampoules (solution for injection), eye drops oftan) drugs for the treatment of inflammation in adults, children and pregnancy.

Composition

  • Active substance - dexamethasone sodium phosphate (in terms of dexamethasone phosphate) - 4.0 mg / 8.0 mg;
  • Excipients - glycerin, disodium phosphate dihydrate, disodium edetate, water for injection.

Release forms

  1. Tablets 0.5 mg;
  2. Solution in ampoules for intravenous and intramuscular administration (injections for injections) 4 mg/ml;
  3. Eye drops Oftan 0.1%;
  4. Eye suspension 0.1%

DEXAMETHASONE instructions for use of the drug

Oral administration of Dexamethasone in the form of tablets involves the appointment of 10-15 mg of the drug per day at the initial stage of treatment, followed by a decrease in the daily dose to 2-4.5 mg with maintenance therapy. The instruction recommends dividing the daily dose of the drug Dexamethasone into 2-3 doses (after or during meals).

Maintenance small doses should be taken once a day, preferably in the morning. Dexamethasone in ampoules is intended for intravenous (drip or jet), intramuscular, periarticular and intraarticular administration. The recommended daily dose of Dexamethasone for these routes of administration is 4-20 mg. Dexamethasone in ampoules is usually used 3-4 times a day for 3-4 days, followed by switching to tablets.

Dexamethasone drops are used in ophthalmology: in acute conditions, 1-2 drops of the drug are instilled into the conjunctival sac every 1-2 hours, when the condition improves, every 4-6 hours. Chronic processes involve the use of Dexamethasone drops 2 times a day.

The duration of treatment depends on clinical course diseases, so Dexamethasone drops can be used from several days to four weeks.

Indications for the use of Dexamethasone

Diseases requiring the introduction of a fast-acting GCS, as well as cases where oral administration of the drug is not possible:

  • Shock (burn, traumatic, surgical, toxic) - with the ineffectiveness of vasoconstrictors, plasma-substituting drugs and other symptomatic therapy;
  • Severe allergic reactions, anaphylactic shock;
  • Blood diseases: acute hemolytic anemia, agranulocytosis, idiopathic thrombocytopenic purpura in adults;
  • Endocrine diseases: acute insufficiency of the adrenal cortex, primary or secondary insufficiency, congenital hyperplasia, subacute thyroiditis;
  • Local application (in the area of ​​pathological formation): keloids, discoid lupus erythematosus, granuloma annulare;
  • Rheumatic diseases - Dexamethasone instructions for use;
  • IN ophthalmic practice(subconjunctival, retrobulbar or parabulbar administration): allergic conjunctivitis, keratitis, keratoconjunctivitis without epithelial damage, iritis, iridocyclitis, blepharitis, blepharoconjunctivitis, scleritis, episcleritis, inflammatory process after eye injuries and surgical interventions, sympathetic ophthalmia, immunosuppressive treatment after corneal transplantation;
  • Acute severe dermatoses;
  • Malignant diseases: palliative treatment of leukemia and lymphoma in adult patients; acute leukemia in children; hypercalcemia in patients suffering from malignant tumors, when oral treatment is not possible;
  • Severe infectious diseases (in combination with antibiotics);
  • Cerebral edema (with a tumor, traumatic brain injury, neurosurgical intervention, hemorrhage, encephalitis, meningitis, radiation injury);
  • Systemic diseases connective tissue;
  • Asthmatic status; severe bronchospasm (exacerbation bronchial asthma, chronic obstructive bronchitis).

What are Dexamethasone tablets used for?

  • With hypothyroidism (a condition with a persistent lack of thyroid hormones);
  • At rheumatoid arthritis in the acute phase;
  • With congenital adrenogenital syndrome (hyperfunction of the adrenal cortex and increased content androgens in the body)
  • With Addison-Birmer disease (loss of the ability of the adrenal glands to produce hormones in sufficient quantities);
  • With pemphigus (a skin disease that manifests itself in the form of blisters on the hands, genitals, mouth, etc.);
  • In acute and subacute thyroiditis (inflammation of the thyroid gland);
  • With acute erythroderma (reddening of the skin);
  • With progressive ophthalmopathy (an increase in the volume of eye tissues) associated with thyrotoxicosis (intoxication with thyroid hormones);
  • With acute eczema;
  • In diseases of the connective tissue;
  • With malignant tumors (symptomatic therapy);
  • With autoimmune hemolytic anemia;
  • With cerebral edema;
  • With agranulocytosis (decrease in the level of neutrophils in the blood);
  • With bronchial asthma;
  • With serum sickness (immune reaction to foreign serum proteins).

What are Dexamethasone drops prescribed for?

  • With scleritis (inflammation of the deep layers of the sclera of the eye);
  • With keratitis (inflammation of the cornea of ​​\u200b\u200bthe eye);
  • With sympathetic ophthalmia (inflammatory lesions of the eye);
  • With non-purulent and allergic conjunctivitis (inflammation of the mucous membrane of the eye);
  • With iritis (inflammation of the iris of the eye);
  • With blepharitis (inflammation of the edges of the eyelids);
  • In inflammatory processes after eye injuries or operations;
  • With iridocyclitis (inflammation of the iris and ciliary body);
  • With episcleritis (inflammation of the connective tissue between the conjunctiva and the sclera);
  • With keratoconjunctivitis (simultaneous inflammation of the conjunctiva and cornea of ​​the eye) without damage to the epithelium.

Why are injections prescribed in ampoules Dexamethasone

  • With acute hemolytic anemia;
  • With acute insufficiency of the adrenal cortex;
  • With asthmatic status;
  • Acute lymphoblastic leukemia (a malignant disease that affects Bone marrow, spleen, The lymph nodes, thymus and other organs). Dexamethasone instructions for use;
  • With cerebral edema;
  • With severe infectious diseases;
  • With shock of various genesis;
  • With diseases of the joints;
  • With thrombocytopenia;
  • With severe allergic reactions;
  • With acute croup (inflammation of the larynx and upper respiratory tract);
  • with agranulocytosis.

Contraindications

For short-term use for health reasons, the only contraindication is hypersensitivity to dexamethasone or the components of the drug.

In children during the period of growth, corticosteroids should be used only according to absolute indications and under the most careful supervision of the attending physician.

Carefully the drug should be prescribed for the following diseases and conditions:

The therapeutic and toxic effects of Dexamethasone are reduced by barbiturates, phenytoin, rifabutin, carbamazepine, ephedrine and aminoglutethimide, rifampicin (accelerate metabolism); somatotropin; antacids (reduce absorption), enhance - estrogen-containing oral contraceptives. Simultaneous use with cyclosporine increases the risk of seizures in children.

The risk of arrhythmias and hypokalemia is increased by cardiac glycosides and diuretics, the likelihood of edema and arterial hypertension is increased by sodium-containing drugs and nutritional supplements, severe hypokalemia, heart failure and osteoporosis - amphotericin B and carbonic anhydrase inhibitors; the risk of erosive and ulcerative lesions and bleeding from the gastrointestinal tract - non-steroidal anti-inflammatory drugs. Dexamethasone instructions for use.

When used simultaneously with live antiviral vaccines and against the background of other types of immunization, it increases the risk of virus activation and infection.

Simultaneous use with thiazide diuretics, furosemide, ethacrynic acid, carbonic anhydrase inhibitors, amphotericin B can lead to severe hypokalemia, which can increase the toxic effects of cardiac glycosides and non-depolarizing muscle relaxants.

Weakens the hypoglycemic activity of insulin and oral antidiabetic agents; anticoagulant - coumarins; diuretic - diuretic diuretics; immunotropic - vaccination (suppresses antibody production).

It worsens the tolerance of cardiac glycosides (causes a potassium deficiency), reduces the concentration of salicylates and praziquantel in the blood. May increase the concentration of glucose in the blood, which requires dose adjustment of hypoglycemic drugs, sulfonylurea derivatives, asparaginase.

GCS increase the clearance of salicylates, so after the abolition of Dexamethasone, it is necessary to reduce the dose of salicylates. When used simultaneously with indomethacin, the Dexamethasone suppression test may give false negative results.

Dosage and administration

It is intended for intravenous, intramuscular, intraarticular, periarticular and retrobulbar administration. The dosage regimen is individual and depends on the indications, the patient's condition and his response to therapy.

In order to prepare for intravenous drip infusion, an isotonic sodium chloride solution or a 5% dextrose solution should be used. The introduction of high doses of dexamethasone can be continued only until the patient's condition stabilizes, which usually does not exceed 48 to 72 hours.

Adults with acute and emergency conditions administered in / in slowly, stream or drip, or / m at a dose of 4-20 mg 3-4 times a day. Maximum single dose-80 mg. Maintenance dose - 0.2-9 mg per day. The course of treatment is 3-4 days, then they switch to oral administration of Dexamethasone. Children - in / m at a dose of 0.02776-0.16665 mg / kg every 12-24 hours.

  1. Soft tissues: 2 to 6 mg;
  2. Large joints (eg. knee-joint): 2 to 4 mg;
  3. Articular bags: 2 to 3 mg;
  4. Small joints (eg, interphalangeal, temporal joint): 0.8 to 1 mg;
  5. Nerve ganglia: 1 to 2 mg;
  6. Tendons: 0.4 to 1 mg.

The drug is prescribed repeatedly with an interval of 3 days to 3 weeks as needed; maximum dose for adults - 80 mg per day. In shock, adults - in / in 20 mg once, then 3 mg / kg for 24 hours as a continuous infusion or in / in a single dose of 2-6 mg / kg, or in / in 40 mg every 2- 6 o'clock.

With cerebral edema (adults) - 10 mg IV, then 4 mg every 6 hours / m until symptoms disappear; the dose is reduced after 2-4 days and gradually - within 5-7 days - stop treatment. In case of insufficiency of the adrenal cortex (children) in / m at 0.0233 mg / kg (0.67 / mg / m2) per day in 3 injections every third 24 hours, or daily at 0.00776-0.01165 mg / kg ( 0.233-0.335 mg/m2) per day.

With an acute allergic reaction or exacerbation of a chronic allergic disease, dexamethasone should be administered according to the following schedule, taking into account the combination of parenteral and oral administration: dexamethasone instructions for use injection 4 mg / ml: 1 day, 1 or 2 ml (4 or 8 mg) intramuscularly; dexamethasone tablets 0.75 mg: the second and third days, 4 pieces in 2 doses per day, the fourth - 2 pieces in 2 doses, the fifth and sixth days - 1 pc. daily, on the seventh - without treatment, day 8 - observation.

Side effects

Dexamethasone is usually well tolerated. It has low mineralocorticoid activity, i.e. its impact on water-electrolyte exchange small. As a rule, low and medium doses of Dexamethasone do not cause sodium and water retention in the body, increased potassium excretion.

The following side effects have been described:

  1. From the sensory organs: posterior subcapsular cataract, increased intraocular pressure with possible damage optic nerve, tendency to develop secondary bacterial, fungal or viral infections eye, trophic changes cornea, exophthalmos, sudden loss of vision (with parenteral administration in the head, neck, turbinates, scalp, crystals of the drug may be deposited in the vessels of the eye);
  2. On the part of the skin and mucous membranes: delayed wound healing, petechiae, ecchymosis, thinning of the skin, hyper- or hypopigmentation, steroid acne, striae, a tendency to develop pyoderma and candidiasis;
  3. From the side endocrine system: decreased glucose tolerance, steroid diabetes mellitus or manifestation of latent diabetes mellitus, adrenal suppression, Itsenko-Cushing's syndrome (moon face, pituitary-type obesity, hirsutism, increased blood pressure, dysmenorrhea, amenorrhea, muscle weakness, striae), delayed sexual development in children;
  4. From the side of metabolism: increased excretion of calcium, hypocalcemia, weight gain, negative nitrogen balance (increased protein breakdown), excessive sweating. Due to mineralocorticoid activity - fluid and sodium retention (peripheral edema), hypnatremia, hypokalemia syndrome (hypokalemia, arrhythmia, myalgia or muscle spasm, unusual weakness and fatigue);
  5. From the musculoskeletal system: growth retardation and ossification processes in children (premature closure of epiphyseal growth zones), osteoporosis (very rarely, pathological bone fractures, aseptic necrosis of the head of the humerus and femur), rupture of muscle tendons, steroid myopathy, decreased muscle mass (atrophy). Dexamethasone instructions for use;
  6. From the side of cardio-vascular system: arrhythmias, bradycardia (up to cardiac arrest); development (in predisposed patients) or increased severity of heart failure, changes in the electrocardiogram characteristic of hypokalemia, increased blood pressure, hypercoagulability, thrombosis. In patients with acute and subacute myocardial infarction - the spread of necrosis, slowing down the formation of scar tissue, which can lead to rupture of the heart muscle;
  7. From the side digestive system: nausea, vomiting, pancreatitis, steroid gastric ulcer and duodenum, erosive esophagitis, gastrointestinal bleeding and wall perforation gastrointestinal tract, increase or decrease in appetite, indigestion, flatulence, hiccups. In rare cases, an increase in the activity of hepatic transaminases and alkaline phosphatase;
  8. From the side nervous system: delirium, disorientation, euphoria, hallucinations, manic-depressive psychosis, depression, paranoia, increased intracranial pressure, nervousness or anxiety, insomnia, dizziness, vertigo, cerebellar pseudotumor, headache, convulsions.

allergic reactions: skin rash, itching, anaphylactic shock, local allergic reactions.

Local for parenteral administration: burning, numbness, pain, tingling and infection at the injection site, rarely - necrosis of surrounding tissues, scarring; atrophy of the skin and subcutaneous tissue with intramuscular injection (it is especially dangerous to inject into the deltoid muscle).

Other: development or exacerbation of infections (the appearance of this side effect is facilitated by jointly used immunosuppressants and vaccination), leukocyturia, "flushing" of blood to the face, "withdrawal" syndrome.

The price of the drug DEXAMETHASONE

  • Dexamethasone, tablets 0.5 mg, 10 pcs. - 45 rubles;
  • Dexamethasone, eye drops 0.1%, 5 ml - 34 rubles;
  • Dexamethasone, ampoules 4 mg, 1 ml, 25 pcs. - 202 rubles;
  • Dexamethasone solution for injections 4 mg/ml 1 ml ampoules, 25 pcs. 144 rubles;
  • Dexamethasone eye drops, 10 ml - 82 rubles.

special instructions

  • Caution should be used in acute and subacute myocardial infarction - it is possible to spread the focus of necrosis, slow the formation of scar tissue and rupture the heart muscle;
  • During treatment with Dexamethasone, vaccination should not be carried out due to a decrease in its effectiveness (immune response).
    When prescribing Dexamethasone for intercurrent infections, septic conditions and tuberculosis, it is necessary to simultaneously treat with bactericidal antibiotics;
  • Patients with latent infectious diseases of the kidneys and urinary tract Dexamethasone can cause leukocyturia, which may be of diagnostic value;
  • With sudden withdrawal, especially in the case of previous use of high doses, the development of a “withdrawal” syndrome (anorexia, nausea, lethargy, generalized musculoskeletal pain, general weakness), as well as an exacerbation of the disease, for which Dexamethasone was prescribed;
  • During treatment with Dexamethasone (especially long-term), it is necessary to observe an ophthalmologist, control blood pressure and the state of water and electrolyte balance, as well as pictures of peripheral blood and blood glucose levels;
  • In children during long-term treatment with Dexamethasone, careful monitoring of the dynamics of growth and development is necessary. Children who during the treatment period were in contact with patients with measles or chicken pox, prophylactically prescribe specific immunoglobulins.
    Due to the weak mineralocorticoid effect for replacement therapy in adrenal insufficiency, Dexamethasone is used in combination with mineralocorticoids;
  • Dexamethasone increases the content of metabolites of 11- and 17-hydroxyketocorticosteroids;
  • In order to reduce side effects you can prescribe antacids, and you should also increase the intake of K + in the body (diet, potassium supplements). Food should be rich in proteins, vitamins, with limited content of fats, carbohydrates and salt;
  • In patients with diabetes mellitus, blood glucose levels should be monitored and, if necessary, therapy should be adjusted.
    X-ray control of the osteoarticular system (images of the spine, hand) is shown;
  • The effect of the drug is enhanced in patients with hypothyroidism and cirrhosis of the liver. The drug may increase existing emotional instability or psychotic disorders. When indicating a history of psychosis, Dexamethasone in high doses is prescribed under the strict supervision of a physician;
  • In stressful situations during maintenance treatment (for example, surgery, trauma or infectious diseases), the dose of the drug should be adjusted due to an increase in the need for glucocorticosteroids. Patients should be carefully monitored for a year after the end of long-term therapy with Dexamethasone due to the possible development of relative insufficiency of the adrenal cortex in stressful situations. Dexamethasone instructions for use.

Video review of the drug DEXAMETHASONE (DEXAMETHASONE)

If you liked the article Dexamethasone instructions for use, for which injections are prescribed" share your opinion in the comments. Click on any of the buttons below to save to yourself and share it in in social networks. This will be your best "thank you" for the material.

Should be given credit modern pharmacology, which was able to achieve unprecedented success in the field of application hormonal drugs for the treatment of both acute and chronic ailments. The basis of such drugs are synthesized analogues of the body's own hormones. Inflammatory diseases are treated by the use of hormonal drugs, which are more analogous to the secretion of the adrenal cortex. Such drugs allow you to quickly and effectively remove inflammatory processes, which is important to take into account in the development of allergic reactions and in diseases of the joints.

One such drug is a drug called Dexamethasone. This drug refers to glucocorticosteroids, and has a number of beneficial effects. Why Dexamethasone is so useful, let's find out in more detail.

Features of the drug

Dexamethasone is a synthetic type of glucocorticosteroid (hormonal) substances, which is a derivative of fluoroprednisolone. The drug has anti-allergic, anti-inflammatory, immunosuppressive effects, and also allows you to increase the sensitivity of adrenergic receptors. Presented as a solution for injection in ampoules of 1 and 2 ml. The package contains 25 ampoules, and the cost of the drug is about 200 rubles. The solution for injection is a clear or yellowish liquid, depending on the release series. One 1 ml ampoule contains the following components:

  • dexamethasone sodium phosphate 4 mg;
  • sodium chloride;
  • disodium edatate;
  • sodium hydrogen phosphate dodecahydrate;
  • water.

The effectiveness of the drug is determined by the mechanism of its action. This mechanism is associated with several fundamental effects, which are:

  1. After the active substances of the drug enter the human body, their reaction with the receptor protein is observed. After entering the reaction, the active substances penetrate directly into the nucleus of membrane cells.
  2. A number of metabolic processes are activated by inhibiting the phospholipase enzyme.
  3. There is a blocking of the extraction of mediators of inflammatory reactions from the immune system.
  4. Inhibition of the functioning of enzymes that are responsible for the breakdown of proteins. This action has a positive effect on the process of metabolism of cartilage and bone tissue.
  5. Blocking proteins that are involved in the process of inflammatory processes.
  6. Reducing the permeability of small vessels, which contributes to inhibition of the excretion of inflammatory cells.
  7. Decrease in the intensity of production of leukocytes.

Through all of the above factors, it can be noted that the drug Dexamethasone has the following properties:

  • anti-inflammatory;
  • immunosuppressive;
  • antiallergic;
  • anti-shock.

It's important to know! Dexamethasone has an immediate effect on intravenous administration, and with intramuscular injection after 8 hours.

Like any other medicine, the drug Dexamethasone has negative properties, through which an adverse effect is exerted on the human body.

The negative effect of the drug

Dexamethasone has a number of negative factors, which include:

  • depressing effect on immune system, thereby increasing the likelihood of severe infectious diseases and the formation of tumors;
  • an interfering effect on the formation of bone tissue, which becomes possible through an inhibitory effect on calcium absorption;
  • performs the redistribution of fat cells on the body, as a result of which the main amount of adipose tissue is deposited in the body area;
  • retention of water and sodium ions in the kidneys, which prevents the excretion of adrenocorticotropic hormone.

Such negative reactions medicinal product allow you to understand what side effects can be. You can avoid the development of side effects by using the drug in the lowest possible doses, which will reduce the negative impact on the body.

Indications for use

Dexamethasone is popular in many areas of medicine. The drug is used to treat diseases of the joints, as well as to relieve allergic manifestations. Indications for the use of Dexamethasone are the following diseases and pathologies:

  1. Shock conditions of the patient.
  2. swelling of the brain due to the following signs Key words: tumors, craniocerebral injuries, neurosurgical interventions, meningitis, hemorrhages, encephalitis and radiation injuries.
  3. With the development of acute insufficiency of the adrenal cortex.
  4. Sharp Species hemolytic anemia, thrombocytopenia, agranulocytosis, as well as severe infectious diseases.
  5. Acute laryngotracheitis in children.
  6. Rheumatic diseases.
  7. Skin diseases: psoriasis, eczema, dermatitis.
  8. Multiple sclerosis.
  9. Intestinal diseases with unexplained genesis.
  10. Shoulder-scapular periarthritis, bursitis, osteochondrosis, osteoarthritis and others.

Solution for injection Dexamethasone is used in the development of acute and urgent conditions, when a person's life depends on the speed of exposure to the drug. The drug is intended primarily for short-term use in connection with vital indications.

How to apply

Dexamethasone is indicated for use not only for adults, but also for children from the first year of life. Instructions for use of the drug Dexamethasone in the form of injections informs that the drug can be used not only for intramuscular injection, but also intravenously by jet or drip. The dosage of the drug depends on such factors as the severity and form of the disease, the age of the patient and the presence of negative reactions. For intravenous administration by drip infusion, a solution must first be prepared. For preparation, it is necessary to dilute the drug with saline or glucose solution. Let us consider in more detail the features of the use of Dexamethasone for adults and children.

For adults, Dexamethasone is used both intramuscularly and intravenously in an amount of 4 to 20 mg. The maximum dosage per day should not exceed 80 ml, so the drug can be administered 3-4 times a day. If there are acute dangerous cases in which a fatal outcome may occur, then on an individual basis, as directed by a doctor, the daily dose may be increased. The duration of parenteral use of the drug is no more than 3-4 days. If it is necessary to continue treatment, then the oral form of the drug in the form of tablets is used. In the event of a positive effect, the dosage is reduced until a maintenance dose is identified. The decision to stop taking the drug is made by the attending physician.

It is unacceptable to use Dexamethasone in the form of intravenous administration in large doses. fast way. This can lead to the development of cardiac complications, so the drug should be administered slowly. Intramuscularly, the drug should also be administered slowly. With the development of cerebral edema, the initial dosage of the drug should not exceed 16 mg. The subsequent dosage is 5 mg intravenously or intramuscularly every 6 hours until a positive result is achieved. If surgical interventions were performed in the brain area, then such dosages may be required for several more days. Continuous use of the drug can significantly affect the reduction of increased intracranial pressure, which occurs due to the presence of a tumor in the brain.

For children, Dexamethasone injections are prescribed in the form of intramuscular injection. Children's dosage depends on the weight of the child and is 0.2-0.4 mg / kg of body weight per day. Treatment should not be prolonged, and dosages for children should be kept to a minimum, depending on the nature of the disease.

Features of use in articular diseases

Treatment of joint diseases with Dexamethasone is a necessary measure when non-steroidal types of drugs are not able to provide the necessary healing effect. The main indications for the use of Dexamethasone in articular diseases are:

  • Bechterew's disease.
  • Rheumatoid arthritis.
  • Articular syndrome in the development of psoriasis.
  • Lupus and scleroderma with articular involvement.
  • Bursitis.
  • Still's disease.
  • Polyarthritis.
  • synovitis.

In such diseases, Dexamethasone is supposed to be used for both local and general treatment.

It's important to know! The drug is injected into the joint area only in an amount of not more than 1 time. Re-injection of Dexamethasone into the joint area is allowed after 3-4 months. In a year, the number of injections for the joint should not exceed 3-4 times. If the norm is exceeded, then this threatens the development of damage to cartilage tissues.

The dosage for intra-articular use is from 0.4 to 4 mg. The dose is influenced by such features as the age of the patient, the size of the shoulder joint, as well as weight. The dosage should be prescribed by the attending physician after a preliminary examination of the patient. Below is a table that shows the approximate doses for the treatment of articular diseases.

Type of introductionDosage
Intra-articular (general)0.4-4 mg
Introduction to Large Joints2-4 mg
Introduction to small joints0.8-1 mg
Introduction to the bursa2-3 mg
Insertion into the tendon sheath0.4-1 mg
Introduction to the tendon1-2 mg
Local administration (into the affected area)0.4-4 mg
Introduction to Soft Tissues2-6 mg

The data in the table are indicative, so it is very important not to prescribe dosages yourself.

It's important to know! Prolonged intra-articular administration of the drug is unacceptable, as this can lead to tendon ruptures.

Application for allergic diseases

allergic reactions various forms treated with antihistamines. If the inflammatory processes are very strong, then antihistamines do not cope with the task. Dexamethasone comes to the rescue, which is a derivative of prednisone. Active substances act on mast cells, reducing allergic symptoms, resulting in the disappearance of symptoms.

Dexamethasone is used to eliminate allergic manifestations. It is effective for the following allergic abnormalities:

  1. allergic skin diseases such as dermatitis and eczema.
  2. Quincke's edema.
  3. Hives.
  4. Anaphylactic shock.
  5. The development of inflammatory reactions in the nasal mucosa.
  6. Angioedema, manifested on the face and neck.

With the development of allergic reactions, you should immediately contact an allergist who will select the necessary dosage of the drug and will be able to provide timely and correct assistance to the patient.

Features of use during pregnancy

The period of pregnancy and lactation in the life of every woman is a very important stage. During pregnancy, a woman's body is more susceptible to negative factors, due to a decrease in the immune system.

The main feature of Dexamethasone is the fact that its active and metabolic forms of the drug have the ability to penetrate through any barriers. It follows from this that during pregnancy it is necessary to use the drug with extreme caution. When carrying a child, the need to use Dexamethasone is taken by the doctor in each individual case.

An international organization has assigned Class C status to Dexamethasone. This means that the drug can have a negative effect on the fetus, but if there is a risk to the health of the mother, then its use is possible.

Mothers who feed their babies with natural milk should know that it is forbidden to use the medicine in any form during this period. If it is impossible to do without the use of Dexamethasone to cure the disease, then the child should be transferred to artificial feeding. When using Dexamethasone during pregnancy and breastfeeding, the following complications may develop in the fetus and already born child:

  • insufficiency of the adrenal cortex;
  • the formation of congenital malformations;
  • abnormal development of the head and limbs;
  • deterioration in growth and development.

When prescribing Dexamethasone during pregnancy and breastfeeding the physician takes responsibility.

Presence of contraindications

With the development of serious severe complications, such as angioedema or anaphylactic shock, the main contraindication to the use of the drug is the presence of signs of individual intolerance. In all other cases, Dexamethasone will save a life by resuscitating the patient.

If the drug is prescribed as a prophylaxis for chronic ailments, then it is important to take into account some types of contraindications. In the presence of such contraindications, the use of the drug can be harmful, so it is very important to take this seriously. The main types of contraindications are:

  1. In the presence of active types of infectious diseases: viral, bacterial and fungal.
  2. With the development of immunodeficiency, which can be both congenital and acquired.
  3. Tuberculosis in the active form of the disease.
  4. Severe osteoporosis.
  5. In the presence of a peptic ulcer of the gastrointestinal tract.
  6. Esophagitis.
  7. With myocardial infarction.
  8. At diabetes.
  9. Mental types of disorders.
  10. Joint fractures.
  11. Internal bleeding.

The main contraindication is intolerance to any component of the drug. All these contraindications should be considered in each individual case. If you use the drug in the presence of contraindications, then this will lead to a deterioration in the condition and the development of side effects. What are the side effects, find out further.

Adverse symptoms

With improper use of Dexamethasone, the following may occur: adverse reactions:

  1. Hives, allergic dermatitis, rash and angioedema.
  2. Arterial hypertension and encephalopathy.
  3. Heart failure, cardiac arrest or rupture.
  4. Decrease in the number of lymphocytes and monocytes, as well as thrombocytopenia.
  5. Swelling of the optic disc. The development of neurological side effects as well as seizures, dizziness and sleep disturbances.
  6. Mental disorders, insomnia, depressive psychosis, hallucinations, paranoia, schizophrenia.
  7. Adrenal atrophy, growth problems in children, disorders menstrual cycle, increased appetite and weight, hypocalcemia.
  8. Nausea, vomiting, hiccups, stomach ulcers, internal bleeding in the gastrointestinal tract, pancreatitis and gallbladder perforation.
  9. Muscle weakness, osteoporosis, articular cartilage damage and bone necrosis, tendon rupture.
  10. Delayed wound healing, itching, bruising, erythema, excessive sweating.
  11. Excessive intraocular pressure, glaucoma, cataracts, exacerbation of bacterial and viral eye infections.
  12. development of impotence.
  13. Pain at the injection site. Atrophy of the skin, scarring at the injection site.

The development of nosebleeds, as well as increased pain in the joints. The development of side effects in patients who, after undergoing a course of therapy, abruptly completed treatment, is not excluded. These side effects include the following ailments: adrenal insufficiency, arterial hypotension, and death.

It's important to know! With the development of side symptoms, as well as with complications and ailments, you must immediately inform your doctor about this. The course of treatment should be stopped immediately if the patient's condition worsens.

Dexamethasone is available from several manufacturers. In addition, it should be noted that the drug has analogues:

  • Dexaven;
  • Dexamed;
  • Dexon;
  • Decadron;
  • Dexafar.

Advantages and disadvantages

What are the advantages and disadvantages of Dexamethasone? Having received an answer to this question, we can conclude that the use of the drug is appropriate. But when it comes to life, the doctor does not think about the presence of contraindications and side effects, and prescribes the medicine urgently. Another thing is when systemic long-term treatment is planned, then in this case it is important to weigh all the pros and cons.

The main advantages of Dexamethasone are:

  1. Rapid and pronounced positive effect after the administration of the drug.
  2. Wide range of influences.
  3. The possibility of using the drug in various convenient forms. The injectable has the fastest effect.
  4. The low cost of the drug, since the packaging will cost 200 rubles.
  5. The possibility of using the drug both in a single dosage and with maintenance.

It is also important to take into account the disadvantages of the drug, which are not so few:

  1. Large list of adverse reactions.
  2. Limited possibility of prescribing the drug during breastfeeding and pregnancy.
  3. The need to choose the lowest possible dosage of the drug.
  4. The need to control the intake of the drug.
  5. Absence dosage forms in the form of ointments and gels, which would be useful for articular pathologies.
  6. Glucose during pregnancy: intravenous administration for the correction of physiological processes Injection with Mydocalm: instructions for use

Catad_pgroup Systemic corticosteroids

Catad_pgroup Preparations for ophthalmology

Dexamethasone for injection - instructions for use

INSTRUCTIONS for medical use drug

Name of the medicinal product:

Trade name of the drug:

Dexamethasone

International non-proprietary name:

dexamethasone

Dosage form:

injection

Composition

Active substance:
Dexamethasone sodium phosphate (dexamethasone phosphate disodium salt) in terms of 100% substance - 4.0 mg

Excipients:
glycerol (distilled glycerin) - 22.5 mg
disodium edetate (trilon B) - 0.1 mg
sodium hydrogen phosphate dodecahydrate (sodium phosphate disubstituted 12-water) - 0.8 mg
water for injection - up to 1 ml

Pharmacotherapeutic group:

glucocorticosteroid

ATC code:

H02AB02

Description:

clear colorless or light yellow liquid.

pharmachologic effect

Synthetic glucocorticosteroid is a methylated derivative of fluoroprednisolone. It has anti-inflammatory, anti-allergic, desensitizing, anti-shock, anti-toxic and immunosuppressive effects.

Interacts with specific cytoplasmic receptors and forms a complex that penetrates the cell nucleus and stimulates mRNA synthesis; the latter induces the formation of proteins, incl. lipocortin mediating cellular effects. Lipocortin inhibits phospholipase A2, inhibits the release of arachidonic acid and inhibits the biosynthesis of endoperoxides, prostaglandins, leukotrienes, which promote inflammation, allergies, and others.

Protein metabolism: reduces the amount of protein in plasma (due to globulins) with an increase in the albumin / globulin ratio, increases the synthesis of albumins in the liver and kidneys; enhances protein catabolism in muscle tissue.

Lipid metabolism: increases the synthesis of higher fatty acids and triglycerides, redistributes fat (accumulation of fat mainly in the shoulder girdle, face, abdomen), leads to the development of hypercholesterolemia.

Carbohydrate metabolism: increases the absorption of carbohydrates from the gastrointestinal tract; increases the activity of glucose-6-phosphatase, which leads to an increase in the flow of glucose from the liver into the blood; increases the activity of phosphoenolpyruvate carboxylase and the synthesis of aminotransferases, leading to the activation of gluconeogenesis.

Antagonistic action in relation to vitamin D: "washing out" of calcium from the bones and increasing its renal excretion.

The anti-inflammatory effect is associated with inhibition of the release of inflammatory mediators by eosinophils; inducing the formation of lipocortins and reducing the number of mast cells that produce hyaluronic acid; with a decrease in capillary permeability; stabilization of cell membranes and organelle membranes (especially lysosomal ones).

The antiallergic effect is due to a decrease in the number of circulating eosinophils, which leads to a decrease in the release of immediate allergy mediators; reduces the effect of allergy mediators on effector cells.

The immunosuppressive effect is due to inhibition of the release of cytokines (interleukin1 and interleukin2, interferon gamma) from lymphocytes and macrophages.

Suppresses the synthesis and secretion of adrenocorticotropic hormone and secondarily - the synthesis of endogenous glucocorticosteroids. The peculiarity of the action is a significant inhibition of the function of the pituitary gland and the almost complete absence of mineralocorticosteroid activity.

Doses of 1-1.5 mg / day inhibit the function of the adrenal cortex; the biological half-life is 32-72 hours (the duration of the inhibition of the hypothalamus-pituitary-adrenal cortex system).

According to the strength of glucocorticosteroid activity, 0.5 mg of dexamethasone corresponds to approximately 3.5 mg of prednisone (or prednisolone), 15 mg of hydrocortisone, or 17.5 mg of cortisone.

Pharmacokinetics
In the blood, it binds (60-70%) to a specific protein - the carrier - transcortin. Easily passes through histohematic barriers (including through the blood-brain barrier and placental). A small amount is excreted in breast milk. Metabolized in the liver (mainly by conjugation with glucuronic and sulfuric acids) to inactive metabolites. Excreted by the kidneys.

Indications for use:

The drug is used for diseases requiring the introduction of a fast-acting glucocorticosteroid, as well as in cases where oral administration of the drug is not possible:

Endocrine diseases (acute insufficiency of the adrenal cortex, primary or secondary insufficiency of the adrenal cortex, congenital hyperplasia of the adrenal cortex, subacute thyroiditis);
- shock resistant to standard therapy; anaphylactic shock;
- cerebral edema (with a brain tumor, traumatic brain injury, neurosurgical intervention, cerebral hemorrhage, encephalitis, meningitis, radiation injury);
- status asthmaticus; severe bronchospasm (exacerbation of bronchial asthma, chronic obstructive bronchitis);
- severe allergic reactions;
- rheumatic diseases;
- systemic connective tissue diseases;
- acute severe dermatoses;
- malignant diseases(palliative treatment of leukemia and lymphoma in adult patients; acute leukemia in children; hypercalcemia in patients suffering from malignant tumors when oral treatment is not possible);
- diagnostic study of hyperfunction of the adrenal glands;
- blood diseases (acute hemolytic anemia, agranulocytosis, idiopathic thrombocytopenic purpura in adults);
- severe infectious diseases (in combination with antibiotics);
- intra-articular and intra-synovial administration: arthritis various etiologies, osteoarthritis, acute and subacute bursitis, acute tendovaginitis, epicondylitis, synovitis;
- local application (in the area of ​​pathological formation): keloids, discoid lupus erythematosus, granuloma annulare.

Contraindications for use:

For short-term use according to "vital" indications, the only contraindication is hypersensitivity.

For intra-articular administration: previous arthroplasty, pathological bleeding (endogenous or caused by the use of anticoagulants), intra-articular bone fracture, infectious (septic) inflammatory process in the joint and periarticular infections (including history), as well as general infection, pronounced periarticular osteoporosis, no signs of inflammation in the joint (the so-called "dry" joint, for example, in osteoarthritis without synovitis), severe bone destruction and joint deformity (sharp narrowing of the joint space, ankylosis), joint instability as an outcome of arthritis, aseptic necrosis of the joints forming epiphyses of bones.

Post-vaccination period (period lasting 8 weeks before and 2 weeks after vaccination), lymphadenitis after BCG vaccinations. Immunodeficiency states (including AIDS or HIV infection).

Diseases of the gastrointestinal tract (gastric ulcer and 12 duodenal ulcer, esophagitis, gastritis, acute or latent peptic ulcer, recently created intestinal anastomosis, ulcerative colitis with the threat of perforation or abscess formation, diverticulitis).

Diseases of the cardiovascular system, incl. recent myocardial infarction (in patients with acute and subacute myocardial infarction, the focus of necrosis may spread, slowing down the formation of scar tissue and, as a result, rupture of the heart muscle), decompensated chronic heart failure, arterial hypertension, hyperlipidemia.

Endocrine diseases - diabetes mellitus (including impaired carbohydrate tolerance), thyrotoxicosis, hypothyroidism, Itsenko-Cushing's disease.

Severe chronic renal and / or liver failure, nephrourolithiasis. Hypoalbuminemia and conditions predisposing to its occurrence.

Systemic osteoporosis, myasthenia gravis, acute psychosis, obesity (III-IV stage), poliomyelitis (except for the form of bulbar encephalitis), open-angle and angle-closure glaucoma, pregnancy, lactation.

For intra-articular administration: the general serious condition of the patient, the ineffectiveness (or short duration) of the action of 2 previous injections (taking into account the individual properties of the glucocorticosteroids used).

Dosage and administration:

Intra-articular, in the lesion - 0.2-6 mg, repeated 1 time in 3 days or 3 weeks.

Intramuscularly or intravenously - 0.5-9 mg / day.

For the treatment of cerebral edema - 10 mg in the first injection, then 4 mg intramuscularly every 6 hours until the symptoms disappear. The dose can be reduced after 2-4 days with a gradual withdrawal in the period of 5-7 days after the elimination of cerebral edema. Maintenance dose - 2 mg 3 times / day.

For the treatment of shock, 20 mg intravenously at the first injection, then 3 mg/kg for 24 hours as an intravenous infusion or intravenous bolus - from 2 to 6 mg/kg as a single injection or 40 mg as a single injection given every 2- 6 h; possible intravenous administration of 1 mg / kg once. Shock therapy should be canceled as soon as the patient's condition stabilizes, the usual duration is no more than 2-3 days.

Allergic diseases - intramuscularly in the first injection of 4-8 mg. Further treatment is carried out with oral dosage forms.

With nausea and vomiting, during chemotherapy - intravenously 8-20 mg 5-15 minutes before a chemotherapy session. Further chemotherapy should be carried out using oral dosage forms.

For the treatment of respiratory distress syndrome in newborns - intramuscularly 4 injections of 5 mg every 12 hours for two days.

The maximum daily dose is 80 mg.

For children: for the treatment of adrenal insufficiency - intramuscularly at 23 mcg / kg (0.67 mg / sq. M) every 3 days, or 7.8-12 mcg / kg (0.23-0.34 mg / sq. m.). m / day), or 28-170 mcg / kg (0.83-5 mg / sq. m) every 12-24 hours.

Precautions for use

Children who are in contact with patients with measles or chicken pox during the treatment period are prescribed special immunoglobulins prophylactically.
In children during the period of growth, glucocorticosteroids should be used only according to absolute indications and under the most careful supervision of a physician.
It should be borne in mind that in patients with hypothyroidism, the clearance of glucocorticosteroids decreases, and in patients with thyrotoxicosis it increases.

Overdose

Symptoms: increased blood pressure, edema, peptic ulcer, hyperglycemia, impaired consciousness.
Treatment: symptomatic, there is no specific antidote.

Side effect

The frequency of development and severity of side effects depend on the duration of use, the size of the dose used and the possibility of observing the circadian rhythm of the appointment.

From the side of metabolism: sodium and water retention in the body; hypokalemia; hypokalemic alkalosis; negative nitrogen balance caused by increased protein catabolism, increased appetite, weight gain.

From the side of the cardiovascular system: higher risk of thrombosis (especially in immobilized patients), arrhythmias, increased blood pressure, development or aggravation of chronic heart failure, myocardial dystrophy, steroid vasculitis.

From the musculoskeletal system: muscle weakness, steroid myopathy, decreased muscle mass, osteoporosis, vertebral compression fractures, aseptic necrosis of the femoral head and humerus, pathological fractures of long bones.

From the digestive system: nausea, vomiting, erosive and ulcerative lesions of the gastrointestinal tract (which can cause perforations and bleeding), hepatomegaly, pancreatitis, ulcerative esophagitis.

Dermatological reactions: thinning and vulnerability of the skin, petechiae and subcutaneous hemorrhages, ecchymosis, striae, steroid acne, delayed wound healing, increased sweating.

From the side of the central nervous system: fatigue, dizziness, headache, mental disorders, convulsions and false symptoms of a brain tumor (increased intracranial pressure with congestive optic disc).

From the endocrine system: decreased glucose tolerance, "steroidal" diabetes mellitus or manifestation of latent diabetes mellitus, suppression of adrenal function, Itsenko-Cushing's syndrome (moon face, pituitary-type obesity, hirsutism, increased blood pressure, dysmenorrhea, amenorrhea, myasthenia gravis, striae), delayed sexual development in children.

From the side of the organs of vision: posterior subcapsular cataract, increased intraocular pressure, exophthalmos.

Side effects associated with immunosuppressive action: more frequent occurrence of infections and aggravation of the severity of their course.

Others: allergic reactions.

Local reactions (at the injection site): hyperpigmentation and leukoderma, atrophy of subcutaneous tissue and skin, aseptic abscess, hyperemia at the injection site, arthropathy.

Interaction with other drugs

Simultaneous use with phenobarbital, rifampicin, phenytoin or ephedrine can accelerate the biotransformation of dexamethasone, thereby weakening its effect. Hormonal contraceptives enhance the effect of dexamethasone.

Simultaneous use with diuretics (especially "loop") can lead to increased excretion of potassium from the body.

With simultaneous appointment with cardiac glycosides, the possibility of cardiac arrhythmias increases.

Dexamethasone weakens (rarely enhances) the effect of coumarin derivatives, which requires dose adjustment.

Dexamethasone enhances the side effects of non-steroidal anti-inflammatory drugs, especially their effect on the gastrointestinal tract (increased risk of erosive and ulcerative lesions and bleeding from the gastrointestinal tract). In addition, it reduces the concentration of non-steroidal anti-inflammatory drugs in the blood serum and thereby their effectiveness.

Carbonic anhydrase inhibitors: increase the risk of hypernatremia, edema, hypokalemia, osteoporosis.

Reduces the effectiveness of insulin and oral hypoglycemic drugs, antihypertensive drugs.

Antacids weaken the effect of dexamethasone.

In combination with paracetamol leads to an increased risk of hepatotoxicity, due to the induction of liver enzymes and the formation of a toxic metabolite of paracetamol.

The simultaneous use of androgens, steroid anabolics contributes to the appearance of edema, hirsutism and acne; estrogen, oral contraceptives - leads to a decrease in clearance, an increase in the toxic effects of dexamethasone.

The risk of developing cataracts increases with the use of antipsychotics (neuroleptics) and azathioprine in combination with dexamethasone.

Simultaneous administration with M-anticholinergics (including antihistamines, tricyclic antidepressants) and nitrates contributes to the development of glaucoma.

When used simultaneously with live antiviral vaccines and against the background of other types of immunizations, it increases the risk of virus activation and the development of infections.

Amphotericin B increases the risk of developing heart failure.

In combination with anticoagulants and thrombolytics, the risk of developing gastrointestinal ulcers and bleeding increases.

Reduces the plasma concentration of salicylates (increases the excretion of salicylates).

Increases the metabolism of mexiletine, reducing its plasma concentration.

Possibilities and features of the use of the drug during pregnancy

(especially in the first trimester), the drug can be used only when the expected therapeutic effect outweighs the potential risk to the fetus. With prolonged therapy during pregnancy, the possibility of impaired fetal growth is not ruled out. In the case of use at the end of pregnancy, there is a risk of atrophy of the adrenal cortex in the fetus, which may require replacement therapy in the newborn.

If it is necessary to carry out drug treatment during breastfeeding then breastfeeding should be discontinued.

The effect of the drug on the ability to drive vehicles, mechanisms

During treatment, driving is not recommended, as well as engaging in activities that require quick psychomotor reactions and precise movements.

Release form:

Solution for injections 4 mg/ml.

1 ml in neutral glass ampoules.

10 ampoules, together with instructions for use and a knife for opening ampoules or an ampoule scarifier, are placed in a cardboard box.

5 ampoules in a blister pack made of polyvinyl chloride film.

1 or 2 blister packs, together with instructions for use and a knife for opening ampoules or an ampoule scarifier, are placed in a pack of cardboard.

When using ampoules with notches, rings and break points, an ampoule scarifier or a knife for opening ampoules may not be inserted.

Best before date:

2 years. Do not use after the expiry date stated on the packaging.

Storage conditions:

In a place protected from light at a temperature of 5 to 25 ° C.
Keep out of the reach of children.

Conditions for dispensing from pharmacies:

Released by prescription.

Name, address of the manufacturer and address of the place of manufacture of the medicinal product / organization accepting claims

JSC DALHIMFARM, 680001, the Russian Federation, Khabarovsk Territory, Khabarovsk, st. Tashkentskaya, 22.

INN: Dexamethasone

Manufacturer: Krka, d.d., Novo Mesto

Anatomical-therapeutic-chemical classification: Dexamethasone

Registration number in the Republic of Kazakhstan: No. RK-LS-5 No. 003394

Registration period: 05.08.2016 - 05.08.2021

Instruction

Tradename

Dexamethasone

International non-proprietary name

Dexamethasone

Dosage form

Solution for injection, 4 mg/ml

Composition

One ampoule contains

active substance- dexamethasone sodium phosphate 4.37 mg (equivalent to dexamethasone phosphate 4.00 mg),

inexcipients: glycerin, disodium edetate, sodium hydrogen phosphate dihydrate, water for injection.

Description

Clear, colorless to light yellow solution

Pharmacotherapeutic group

Corticosteroids for systemic use. Glucocorticosteroids. Dexamethasone.

ATX code H02AB02

Pharmacological properties

Pharmacokinetics

After intravenous administration, the drug begins to act quickly, and after intramuscular administration, the clinical effect is achieved after 8 hours. The action of the drug is prolonged and lasts from 17 to 28 days after intramuscular injection and from 3 days to 3 weeks after local application (in the affected area). A dose of 0.75 mg dexamethasone is equivalent to a dose of 4 mg methylprednisolone and triamcinolone, 5 mg prednisone and prednisolone, 20 mg hydrocortisone, and 25 mg cortisone. In plasma, about 77% of dexamethasone binds to plasma proteins, and the majority is converted to albumin. Only a minimal amount of dexamethasone binds to non-albumin proteins. Dexamethasone is a fat soluble compound. The drug is initially metabolized in the liver. Small amounts of dexamethasone are metabolized in the kidneys and other organs. The predominant excretion occurs through the urine. The half-life (T1 \ 2) is about 190 minutes.

Pharmacodynamics

Dexamethasone is a synthetic adrenal hormone (corticosteroid) with glucocorticoid action. The drug has a pronounced anti-inflammatory, anti-allergic and desensitizing effect, has immunosuppressive activity.

To date, enough information has been accumulated on the mechanism of action of glucocorticoids to imagine how they act at the cellular level. There are two well-defined receptor systems found in the cytoplasm of cells. Through glucocorticoid receptors, corticosteroids exert anti-inflammatory and immunosuppressive effects and regulate glucose homeostasis; through mineralocorticoid receptors, they regulate sodium and potassium metabolism, as well as water and electrolyte balance.

Indications for use

Dexamethasone is administered intravenously or intramuscularly into acute cases or if oral therapy is not possible:

    replacement therapy for primary and secondary (pituitary) adrenal insufficiency

    congenital adrenal hyperplasia

    subacute thyroiditis and severe forms of postradiation thyroiditis

    rheumatic fever

    acute rheumatic heart disease

    pemphigus, psoriasis, dermatitis (contact dermatitis affecting a large surface of the skin, atopic, exfoliative, bullous herpetiform, seborrheic, etc.), eczema

    toxidermia, toxic epidermal necrolysis (Lyell's syndrome)

    malignant exudative erythema (Stevens-Johnson syndrome)

    allergic reactions to drugs and food

    serum sickness, drug exanthema

    urticaria, angioedema

    allergic rhinitis, hay fever

    diseases that threaten the loss of vision (acute central chorioretinitis, inflammation of the optic nerve)

    allergic conditions (conjunctivitis, uveitis, scleritis, keratitis, iritis)

    systemic immune diseases (sarcoidosis, temporal arteritis)

    proliferative changes in the orbit (endocrine ophthalmopathy, pseudotumors)

    sympathetic ophthalmia

    immunosuppressive therapy in corneal transplantation

The drug is used systemically or locally (in the form of subconjunctival, retrobulbar or parabulbar injections):

    ulcerative colitis

    Crohn's disease

    local enteritis

    sarcoidosis (symptomatic)

    acute toxic bronchiolitis

    Chronical bronchitis and asthma (exacerbations)

    agranulocytosis, panmyelopathy, anemia (including autoimmune hemolytic, congenital hypoplastic, erythroblastopenia)

    idiopathic thrombocytopenic purpura

    secondary thrombocytopenia in adults, lymphoma (Hodgkin's, non-Hodgkin's)

    leukemia, lymphocytic leukemia (acute, chronic)

    kidney disease of autoimmune origin (including acute glomerulonephritis)

    nephrotic syndrome

    palliative care for leukemia and lymphoma in adults

    acute leukemia in children

    hypercalcemia in malignant neoplasms

    cerebral edema due to primary tumors or metastases to the brain, due to craniotomy or head trauma.

Shock of various origins

    shock not responding to standard therapy

    shock in patients with adrenal insufficiency

    anaphylactic shock (intravenously, after the introduction of adrenaline)

Other indications

Indications for intra-articular administration of dexamethasone or injection into soft tissues:

    rheumatoid arthritis (severe inflammation in a single joint)

    ankylosing spondylitis (when inflamed joints do not respond to standard therapy)

    psoriatic arthritis (oligoarticular lesion and tendosynovitis)

    monoarthritis (after removal of intra-articular fluid)

    osteoarthritis (only in the presence of exudate and synovitis)

    extra-articular rheumatism (epicondylitis, tendosynovitis, bursitis)

Local administration (injections into the lesion):

  • hypertrophic, inflamed, and infiltrated lesions of lichen, psoriasis, granuloma annulare, sclerosing folliculitis, discoid lupus, and cutaneous sarcoidosis

    localized alopecia

Dosage and administration

Doses are set individually for each patient, depending on the nature of the disease, the expected duration of treatment, the tolerability of corticosteroids and the patient's response to therapy.

Parenteral application

The solution for injection is administered intravenously or intramuscularly, as well as in the form of intravenous infusions (with glucose or saline).

The recommended average initial daily dose for intravenous or intramuscular administration varies from 0.5 mg to 9 mg and, if necessary, more. The initial dose of dexamethasone should be used until the clinical effect is achieved; then the dose is gradually reduced to the minimum effective. During the day, you can enter from 4 to 20 mg of Dexamethasone 3-4 times. The duration of parenteral administration is usually 3-4 days, then they switch to maintenance therapy with the oral form of the drug.

Local administration

The recommended single dose of dexamethasone for intra-articular administration is from 0.4 mg to 4 mg. Intra-articular injection can be repeated after 3-4 months. Injections into the same joint can only be done 3-4 times in a lifetime, and injections into more than two joints at the same time should not be made. More frequent administration of dexamethasone can lead to damage to intra-articular cartilage and bone necrosis. The dose depends on the size of the affected joint. The usual dose of dexamethasone is 2 mg to 4 mg for large joints and 0.8 mg to 1 mg for small joints.

The usual dose of dexamethasone for intraarticular capsule administration is 2 mg to 3 mg, for administration into the tendon sheath, 0.4 mg to 1 mg, and for tendons, 1 mg to 2 mg.

When administered to limited lesions, the same doses of dexamethasone are used as for intra-articular administration. The drug can be administered simultaneously, at most, in two foci.

Dosing in children

When administered intramuscularly, the dose for replacement therapy is 0.02 mg / kg of body weight or 0.67 mg / m2 of body surface area, which is divided into 3 injections with an interval of 2 days, or from 0.008 mg to 0.01 mg / kg of body weight body or 0.2 mg to 0.3 mg/m2 of body surface area daily. For other indications, the recommended dose is 0.02 mg to 0.1 mg/kg body weight, or 0.8 mg to 5 mg/m2 body surface area, every 12 to 24 hours.

Side effects

    decreased glucose tolerance, "steroidal" diabetes mellitus, or manifestation of latent diabetes mellitus

    Itsenko-Cushing's syndrome, weight gain

    hiccups, nausea, vomiting, increased or decreased appetite, flatulence, increased activity of "liver" transaminases and alkaline phosphatase, pancreatitis

    "steroid" ulcer of the stomach and duodenum, erosive zophagitis, bleeding and perforation of the gastrointestinal tract

    arrhythmias, bradycardia (up to cardiac arrest), development (in predisposed patients) or increased severity of chronic heart failure, increased blood pressure

    hypercoagulation, thrombosis

    delirium, disorientation, euphoria, hallucinations, manic-depressive psychosis, depression, paranoia

    increased intracranial pressure, nervousness, anxiety, insomnia, headache, dizziness, convulsions, vertigo

    pseudotumor of the cerebellum

    sudden loss of vision (with parenteral administration, crystals of the drug may be deposited in the vessels of the eye), posterior subcapsular cataract, increased intraocular pressure with possible damage to the optic nerve, trophic changes in the cornea, exophthalmos, development of secondary bacterial, fungal or viral eye infections

    negative nitrogen balance (increased protein breakdown), hyperlipoproteinemia

    increased sweating

    fluid and sodium retention (peripheral edema), hyperkalemia syndrome (hypokalemia, arrhythmia, myalgia or muscle spasm, unusual weakness and fatigue)

    growth retardation and ossification processes in children (premature closure of the epiphyseal growth zones)

    increased excretion of calcium, osteoporosis, pathological bone fractures, aseptic necrosis of the head of the humerus and femur, tendon rupture

    "steroid" myopathy, muscle atrophy

    delayed wound healing, a tendency to develop pyoderma and candidiasis

    petechiae, ecchymosis, thinning of the skin, hyper- or hypopigmentation,

steroid acne, striae

    generalized and local allergic reactions

    decreased immunity, development or exacerbation of infections

    leukocyturia

    violation of the secretion of sex hormones (menstrual irregularities, hirsutism, impotence, delayed sexual development in children

    withdrawal syndrome

    burning, numbness, pain, paresthesias and infections, necrosis of surrounding tissues, scarring at the injection site, atrophy of the skin and subcutaneous tissue when administered intramuscularly (injection into the deltoid muscle is especially dangerous), arrhythmias, flushing of blood to the face, convulsions (with intravenous introduction), collapse (with the rapid introduction of large doses)

Contraindications

    hypersensitivity to the active substance or auxiliary components of the drug

    peptic ulcer of the stomach and duodenum

    osteoporosis

    acute viral, bacterial and systemic fungal infections (when appropriate therapy is not used)

    Cushing's syndrome

    pregnancy and lactation

    kidney failure

    cirrhosis of the liver or chronic hepatitis

    acute psychoses

    intramuscular injection is contraindicated in patients with severe disorders of hemostasis (idiopathic thrombocytopenic

    for use in ophthalmic practice: viral and fungal diseases eye

    acute form purulent eye infection in the absence of a specific

therapy, corneal diseases associated with epithelial defects, trachoma, glaucoma

    active tuberculosis

Drug Interactions

The effectiveness of dexamethasone is reduced when taken concomitantly rifampicin, carbamazepine, phenobarbitone, phenytoin (diphenylhydantoin), primidone, ephedrine, or aminoglutethimide. Dexamethasone reduces therapeutic effect hypoglycemic drugs, antihypertensive drugs, praziquantel and natriuretics; dexamethasone increases activity heparin, albendazole and kaliuretics. Dexamethasone may change the action coumarin anticoagulants.

Simultaneous use of dexamethasone and high doses glucocorticoids or agonists2-receptor increases the risk of developing hypokalemia. Higher arrhythmogenicity and toxicity of cardiac glycosides is noted in patients suffering from hypokalemia.

With the simultaneous use of oral contraceptives, the half-life of glucocorticoids may increase, which leads to an increase in their action and an increase in the number of side effects.

The simultaneous use of ritodrine and dexamethasone during labor is contraindicated, since this can lead to the death of the mother due to pulmonary edema.

Co-administration of dexamethasone and metoclopramide, diphenhydramine, prochlorperazine, or 5-HT3 receptor antagonists (serotonin or 5-hydroxytryptamine type 3 receptors), such as ondansetron or granisetron, is effective in preventing nausea and vomiting caused by chemotherapy with cisplatin, cyclophosphamide, methotrexate, fluorouracil .

special instructions

Application in pediatrics

In children during long-term treatment, it is necessary to carefully monitor the dynamics of growth and development. In children during the period of growth, glucocorticosteroids should be used only for health reasons and under the most careful supervision of a physician. To prevent disruption of growth processes during long-term treatment of children under the age of 14 years, it is advisable to take a 4-day break in treatment every 3 days.

Children who are in contact with patients with measles, chickenpox during treatment are prescribed specific immunoglobulins.

With diabetes mellitus, tuberculosis, bacterial and amoebic dysentery, arterial hypertension, thromboembolism, heart and kidney failure, nonspecific ulcerative colitis, diverticulitis, recently formed intestinal anastomosis, Dexamethasone should be used very carefully and subject to the possibility of adequate treatment of the underlying disease. If the patient had a history of psychosis, then treatment with glucocorticosteroids is carried out only for health reasons.

With the sudden withdrawal of the drug, especially in the case of high doses, there is a withdrawal syndrome of glucocorticosteroids: anorexia, nausea, lethargy, generalized musculoskeletal pain, general weakness. After discontinuation of the drug for several months, relative insufficiency of the adrenal cortex may persist. If stressful situations arise during this period, temporarily glucocorticoids are prescribed, and if necessary, mineralocorticoids.

Before starting the use of the drug, it is desirable to examine the patient for the presence of ulcerative pathology of the gastrointestinal tract. Patients with a predisposition to the development of this pathology should be prescribed antacids for prophylactic purposes.

During treatment with the drug, the patient should follow a diet rich in potassium, protein, vitamins, with a reduced content of fats, carbohydrates and sodium.

If the patient has intercurrent infections, a septic condition, treatment with Dexamethasone should be combined with antibiotic therapy.

If treatment with Dexamethasone is carried out for 8 weeks before and 2 weeks after active immunization (vaccination), then in this case the effect of immunization will be reduced or completely neutralized.

Patients with severe traumatic brain injury and ischemic cerebrovascular accident should be prescribed glucocorticoids with caution.

Features of influenceon the ability to manage vehicle or potentially dangerous mechanisms

Because Dexamethasone can cause dizziness and headache, when driving vehicles or working with other mechanisms, it is recommended to refrain from driving a car and operating other potentially dangerous mechanisms.

Overdose

Symptoms: possible aggravation of side effects.

Treatment: should be canceled and symptomatic therapy prescribed. There is no specific antidote.

After the disappearance of symptoms of an overdose, the drug is resumed.

Release formand packaging

1 ml in dark glass ampoules with a white dot and a green ring for opening the ampoules. A self-adhesive label is attached to the ampoule.

"Dexamethasone" refers to drugs that can save lives in some cases. Such a hormonal remedy effectively copes with an anaphylactic reaction, bronchospasm, toxic shock and many other dangerous conditions. Not everyone knows when it is prescribed to children, in what form it is used, what adverse reactions it can cause in childhood and what are the consequences of exceeding its dosage.

Release form

"Dexamethasone" is produced in such forms.

Tablets

They are small, round flat shape and often white. One package contains 10 , 20 pieces or more.

Eye drops

They are presented in plastic bottles 5 ,10 ml colorless transparent solution.

Ampoules with a solution for injections into a muscle or vein

One ampoule of this medicine contains 1-2 ml clear solution, which is often colorless, but may be slightly yellowish. One box include 5 or 10 ampoules.

Composition

Main component any form of the drug is represented by dexamethasone in the form of sodium phosphate. This compound is contained in 1 ml of injection solution at a dose of 4 mg, and in one tablet - in the amount of 500 mcg (0.5 mg). The concentration of such a substance in eye drops is 0.1%, which corresponds to 1 mg per 1 ml of solution.

In addition to the active compound, the injection solution contains sterile water, sodium hydrogen phosphate, disodium edetate and glycerol. The eye drops include additional ingredients such as benzalkonium chloride, disodium edetate, water, sodium tetraborate decahydrate, and boric acid. Auxiliary additives in tablet form are lactose, corn starch, colloidal silicon dioxide, povidone, talc and magnesium stearate.

Operating principle

Indications

Dexamethasone injections intramuscularly or intravenously are prescribed in acute cases or in situations where oral administration is not possible. In other cases, a tablet form is used.

The drug is effective:

  • With anaphylactic shock or other severe allergies.
  • With cerebral edema caused by trauma, as well as surgery, meningitis, tumor process and other factors.
  • With insufficiency of the adrenal cortex.
  • With toxic, burn or traumatic shock.
  • With severe bronchospasm or status asthmaticus.
  • With rheumatic or systemic diseases.

  • With severe forms of dermatosis.
  • Crohn's disease or ulcerative colitis.
  • With hemolytic anemia and other blood diseases.
  • With glomerulonephritis.
  • For severe infections.
  • With leukemia and other neoplasms.

The injectable form can also be used topically, for example, injected into a soft tissue lesion, into a joint, or into the tissues of the eyes. For an emergency decrease in body temperature, a lytic mixture with "Dexamethasone", whose components are "Analgin" And "Dimedrol".

Eye drops are used for keratitis, conjunctivitis, iritis, uveitis and other diseases of the organ of vision. Inhalations with "Dexamethasone" are prescribed by doctors for obstructive bronchitis, barking cough, false croup (stenosis of the larynx). The drug is poured into the nebulizer along with saline and the procedure is carried out for 5-10 minutes.

At what age is it allowed to take?

If there are serious indications for the use of Dexamethasone, such a medication can be prescribed at any age, even for a 10-month-old or one-year-old child. At the same time, treatment with such a hormonal agent should only be under medical supervision (both children under one year old and an older child). It is unacceptable to give the drug to children without a doctor's prescription.

Contraindications

Any form of "Dexamethasone" is not used for hypersensitivity to substances in its composition. The drug is contraindicated in acute viral, fungal or bacterial infection. Eye drops should not be used if the integrity of the cornea is damaged.

Injections and tablets are not prescribed for vaccination (when using live vaccines) and for Itsenko-Cushing's syndrome. Injections are prohibited in case of serious problems with hemostasis, and tablets due to the lactose content are not prescribed for violations of carbohydrate metabolism.

Caution in prescribing the drug is required by patients with arterial hypertension, tuberculosis, kidney failure, epilepsy, peptic ulcer, hypothyroidism, liver failure and some other pathologies. If a child has any chronic illness, the question of the appointment of "Dexamethasone" should be decided by a specialist on an individual basis.

Side effects

Dexamethasone treatment can provoke:

  • Cataract or glaucoma.
  • Cardiac disorders - for example, bradycardia, heart failure, or extrasystoles.
  • Weight gain, hyperglycemia, water retention and other metabolic disorders.
  • Increase in blood pressure.
  • Muscle weakness or atrophy.
  • Mental disorders.
  • Slowing wound healing, thinning of the skin, the appearance of stretch marks and acne.
  • Decreased levels of lymphocytes, eosinophils, platelets, or monocytes.

In addition, a local reaction to the medicine may occur - for example, a burning sensation during an injection or redness of the skin after an injection. If you cancel the drug abruptly, this will lead to the development of a withdrawal syndrome, manifested by a decrease in blood pressure, nausea, headache and other negative symptoms.